MOLECULAR PARTNERS AG ADS overview

LOS ANGELES, CA / ACCESSWIRE / September 12, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molecular Partners AG ("Molecular Partners" or "the Company") (NASDAQ:MOLN) for violations of the federal securities laws. Investors who purchased the Company's American Depositary Shares ("ADSs") pursuant and/or traceable to the Company's initial public offering conducted on June 16, 2021 (the "IPO"), and/or between June...

LOS ANGELES, CA / ACCESSWIRE / July 13, 2022 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Molecular Partners AG ("Molecular Partners" or "the Company") (NASDAQ:MOLN) for violations of the federal securities laws. Investors who purchased the Company's American Depositary Shares ("ADSs") pursuant and/or traceable to the Company's initial public offering conducted on June 16, 2021 (the "IPO"), and/or between June 16,...